No. Pharmaceutical research does not and cannot work this way. Over the last few years, there has been much reasearch on molecular interactions. The current consensus is that everthing interacts with pretty much everthing at some point, it is just the degree of these interaction that varies. Molecular pathways become more and more vague (which does not mean that they disappear, its just very complex). For example, we do not even know how many existing drugs interact with each other, because who would fund that? Some reasearch hospital now do it but it is tedious when you have hundreds of potential interacting partners.<p>For clinical trials, this leads to very strict guidelines. One of my university professors once told us about a drug they had to test in dogs for some side effects. Nothing happend to the dogs but afterwards they would have been eutanized because it was regulated that these exact dogs cannot enter another study. They finally adopted them, but still. Similar, people entering clinical trials are usually not allowed to take certain drugs, may need to abstinent from alcohol etc.<p>Keep in mind. This is not an experiment, this is a clinical trial in a human.